1995
DOI: 10.1006/bbrc.1995.2780
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of Angiogenesis by Thrombospondin-2

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
132
2
2

Year Published

1998
1998
2016
2016

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 186 publications
(142 citation statements)
references
References 0 publications
6
132
2
2
Order By: Relevance
“…Although nascent protein strongly inhibits angiogenesis, 31 its ability to bind multiple receptors is disconcerting, since some of these receptors, including integrin-associated protein, mediate functions incompatible with antiangiogenic therapy. 32 Minimal antiangiogenic fragments of TSP1 mapping to the type I repeats and preprocollagen homology domain share GVTRIR consensus sequence 8,33 and block angiogenesis in vitro and in vivo by inducing endothelial cell apoptosis that occurs upon binding to CD36, a cell surface receptor expressed predominantly on the microvascular endothelium. 5,6,10 DI-TSP, a modified GVTRIR-based peptide, blocks endothelial cell functions, angiogenesis and tumor growth with relatively high specific activity.…”
Section: Discussionmentioning
confidence: 99%
“…Although nascent protein strongly inhibits angiogenesis, 31 its ability to bind multiple receptors is disconcerting, since some of these receptors, including integrin-associated protein, mediate functions incompatible with antiangiogenic therapy. 32 Minimal antiangiogenic fragments of TSP1 mapping to the type I repeats and preprocollagen homology domain share GVTRIR consensus sequence 8,33 and block angiogenesis in vitro and in vivo by inducing endothelial cell apoptosis that occurs upon binding to CD36, a cell surface receptor expressed predominantly on the microvascular endothelium. 5,6,10 DI-TSP, a modified GVTRIR-based peptide, blocks endothelial cell functions, angiogenesis and tumor growth with relatively high specific activity.…”
Section: Discussionmentioning
confidence: 99%
“…Stromal angiogenesis control is based on the balance between various angiogenic cytokines and angioinhibitory factors. Thrombospondin (TSP) is an antiangiogenic factor (Iruela et al, 1991;Weinstat et al, 1994;Zabrenetzky et al, 1994;Volpert et al, 1995;Hsu et al, 1996). We detected TSP transcripts in 69% of primary human colon cancer specimens.…”
Section: Discussionmentioning
confidence: 99%
“…Figure 6 shows the effects of IGF-1 deficiency and hypertension on the hippocampal expression of the angiogenesis inhibitors Serpinf1 (PEDF), f i b u l i n -5 ( F b l n 5 ) ( S u l l i v a n e t a l . 2 0 0 7 ) , thromhospondin-1 (Thbs1) (Lawler 2002), Thbs2 (Volpert et al 1995), the potent anti-angiogenic chemokine platelet factor 4 (Pf4) (Bikfalvi 2004); vasohibin-1 (Vash1), which is a newly recognized (Takano et al 2014), Adamts1 ("a disintegrin and metalloproteinase with thrombospondin motifs 1"), which inhibits angiogenesis (Lee et al 2006) by suppressing endothelial cell proliferation; Col18a1, whose expression level impacts endostatin signaling and endothelial angiogenic capacity (Li and Olsen 2004) (endostatin, a potent inhibitor of angiogenesis, is a 20-kDa C-terminal fragment derived from type XVIII collagen); semaphorin-3F (Sema3f) (Ungvari et al 2011b;Frisbee et al 2007); tenomodulin (Tnmd) (Oshima et al 2003); brainspecific angiogenesis inhibitor 1 (Bai1; also known as adhesion G protein-coupled receptor B1 [ADGRB1]) (Nishimori et al 1997); chromogranin A (Chga), which encodes the precursor to several angiogenesis inhibitor peptides including vasostatin-1 and vasostatin-2 (Helle and Corti 2015) and maspin ("mammary serine protease inhibitor"; encoded by the Serpinb5 gene (Qin and Zhang 2010). Figure 7 shows the expression of Tnfa, whose overproduction has been causally linked to microvascular rarefaction (Frisbee et al 2014); Tgfb1, which regulates multiple aspects of the angiogenic process and contributes to hypertension-induced microvascular rarefaction in the heart (Koitabashi et al 2011); Tgfa; angiogenin (Ang, also known as ribonuclease 5), which is a potent stimulator of angiogenesis and an inhibitor of endothelial apoptosis; Edil3 (EGF-like repeats and discoidin Ilike domains 3), which encodes a glycoprotein secreted by endothelial cells that regulates apoptosis, cell migration (Zhong et al 2003) and induces cerebral angiogenesis in mice (Fan et al 2008); midkine (Mdk, also known as neurite growth-promoting factor 2 or NEGF2), which is a pleiotropic growth factor regulating cell proliferation, cell migration and promoting angiogenesis (Mashour et al 2001 [HB-GAM]), which is a pro-angiogenic growth factor that is structurally related to midkine and whose expression in the adult brain is induced by ischemia; Tymp (thymidine phosphorylase, also known as platelet-derived endothelial cell growth factor [ECGF1], which stimulates endothelial cell proliferation and induces angiogenesis in the brain …”
Section: Igf-1 Deficiency Exacerbates Hypertension-induced Cerebromicmentioning
confidence: 99%